ACE2 and viral infectious disease: In COVID -19, a paradoxical viral infection of circulating platelets lacking the required angiotensin-converting enzyme-2 (ACE-2) receptor has been reported in severely ill patients presenting with thrombotic complications associated with SARS-CoV-2 infection (Manne et al. 2020).